Thus, by increasing the production of IFN-γ and GM-CSF, Smad3-silenced NK cell therapy may promote the polarization of APC-like neutrophils with enhanced anti-cancer effects and immunostimulatory functions. This evidence concerns the gene SMAD3 and cancer.